Dermatological Health

Clinical Efficacy of Cryotherapy for Treating Superficial Skin Lesions: A Case Series

2025-04-02T16:24:05+08:00

Objective: To investigate the clinical efficacy of argon gas cryotherapy for treating superficial skin lesions. Methods: Using a cryotherapy device, two patients with superficial skin lesions were treated with argon gas cryotherapy, and the outcomes were observed. Results: Both patients achieved ideal results after three sessions of argon gas cryotherapy, with no recurrence observed during a 3-month follow-up period. Conclusion: Argon gas cryotherapy is effective for treating superficial skin lesions and holds significant clinical value.

Review of New Treatment Methods for Psoriasis and Dermatitis

2025-04-02T16:24:03+08:00

Psoriasis and dermatitis are chronic and troubling skin diseases. To face this challenge, a variety of innovative therapeutic methods came into being. It is necessary to review and summarize the research process of these novel drug therapeutic methods. Local researchers have conducted a comprehensive understanding of the research of traditional medicines, and the research progress of novel therapeutic methods such as biologic drugs and small-molecule targeted drugs has been widely reported. A comprehensive comparison of the new treatments helps to reveal the nuances of each treatment and understand the depth and breadth of its therapeutic effects. New therapeutic approaches, such as cell transplantation, biologic drugs, and small-molecule targeted drugs, are more effective in the treatment of psoriasis and dermatitis than traditional approaches, with minimum side effects. The results of new drug research have opened new possibilities for the treatment of psoriasis and dermatitis, guided the path of future scientific research, and significantly improved the quality of life of patients.

The Relationship Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Psoriasis Curative Effect Treated with Apremilast: A Retrospective Analysis

2025-04-02T16:24:00+08:00

In this study, the changes of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with psoriasis were retrospectively analyzed based on the treatment of apremilast. By screening patients with psoriasis before and after treatment with apremilast, relevant blood routine indicators were collected, and NLR and PLR were calculated. The results showed that both NLR and PLR were significantly reduced after treatment with apremilast. This suggests that the inflammatory response is improved in patients with psoriasis and that apremilast may have an inhibitory effect on white blood cell platelet activation. These results suggest that NLR and PLR may be useful indicators to evaluate the condition of psoriasis and the therapeutic effect of apremilast. This provides a new reference index and treatment strategy for the clinic and has positive practical guiding significance for the prevention and treatment of psoriasis.